Ivermectin is contraindicated in pregnancy and in children below the age of five or below a height of 90 cm.
Doxycycline at a dosage of 100 to 200 mg/d for 4 to 6 weeks kills the Wolbachia endosymbionts, permanently sterilizes adult worms, blocks embryogenesis and slowly kills approximately 60% of adult worms.
A major breakthrough in the battle against onchocerciasis was the ivermectin-donation programme initiated by the producing company Merck. Large control programmes implementing mass drug administration (MDA) of ivermectin in endemic areas in Africa and South America lead to interruption of transmission of onchocerciasis in many countries.
Elimination of the disease is still on the agenda.